This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Basic Science Institute. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Kwang Hoe Kim and Mass Spectrometry-Based Liver Cancer Diagnosis
Introduction
Kwang Hoe Kim is an inventor associated with the Korea Basic Science Institute in Chungcheongbuk-do, South Korea. His patent work includes a diagnostic method that analyzes alpha-fetoprotein-derived glycopeptides using mass spectrometry.
Latest Patents
Kim is associated with 1 patent: “Diagnostic Method of Liver Cancer Using α-Fetoprotein-Derived Glycopeptides by Mass Spectrometry.” The invention analyzes the fucosylation rate of an alpha-fetoprotein glycopeptide with the sequence Val-Asn-Phe-Thr-Glu-Ile-Gln-Lys. The patent describes comparing this rate to help distinguish liver cancer, including early-stage hepatocellular carcinoma, from other liver diseases. It reports that the fucosylation rate is higher in liver cancer patients than in patients with other liver diseases.
Career Highlights
Kim’s listed invention applies mass spectrometry and glycopeptide analysis to cancer diagnosis. The approach focuses on a measurable molecular feature that may support the early identification of liver cancer.
Collaborations
The provided information names Jong Shin Yoo and Jin Young Kim as Kim’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Kwang Hoe Kim’s patent work connects glycopeptide analysis with the potential early diagnosis of liver cancer, reflecting the Korea Basic Science Institute’s research in analytical and biomedical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile